ENvue Medical Holds Special Meeting; Approves Reverse Stock Split Amendment

What Happened ENvue Medical, Inc. (FEED) held a special meeting of stockholders on August 14, 2026 and filed an 8-K reporting the final vote results. Stockholders approved an amendment to the company’s certificate of incorporation authorizing the Board to implement a reverse stock split of the company’s common stock at any ratio between 1-for-2 and 1-for-50, to be determined by the Board and announced publicly before the one-year anniversary of the meeting. A separate adjournment proposal also received sufficient votes but was not used.

Key Details

• Proposal 1 (Reverse Stock Split amendment) — Votes (including preferred stock as converted): For 3,847,974; Against 1,062,981; Abstain 19,288. Proposal was approved.
• Board discretion: The Board may choose the split ratio anywhere from 1-for-2 up to 1-for-50 and must announce the chosen ratio publicly. The action must occur (if taken) before the one-year anniversary of the August 14, 2026 meeting.
• Proposal 2 (Adjournment) — Votes: For 4,199,681; Against 594,319; Abstain 136,243. Although approved, no adjournment motion was made because it was deemed unnecessary.
• No other matters were considered or voted on at the Special Meeting. The filing reports these as the final voting results.

Why It Matters A board-authorized reverse stock split can reduce the number of outstanding shares and increase the per-share price without changing the company’s overall market value. Investors should watch for a future public announcement from ENvue Medical that specifies whether the Board will proceed, the exact split ratio selected, and the effective date — those details will determine the change in share count and per-share price.